KREBS BIOCHEMICALS & INDUSTRIES
Back to Balance Sheet
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹178 Cr | ₹175 Cr | ₹190 Cr | ₹159 Cr | ₹134 Cr |
What is the latest Total Liabilities ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹178 Cr |
Mar2023 | ₹175 Cr |
Mar2022 | ₹190 Cr |
Mar2021 | ₹159 Cr |
Mar2020 | ₹134 Cr |
How is Total Liabilities of KREBS BIOCHEMICALS & INDUSTRIES Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹178 Cr | 1.82 | |
Mar2023 | ₹175 Cr | -7.81 | |
Mar2022 | ₹190 Cr | 19.21 | |
Mar2021 | ₹159 Cr | 19.00 | |
Mar2020 | ₹134 Cr | - |
Compare Total Liabilities of peers of KREBS BIOCHEMICALS & INDUSTRIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KREBS BIOCHEMICALS & INDUSTRIES | ₹166.9 Cr | 5.7% | 1.5% | -6.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,126.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KREBS BIOCHEMICALS & INDUSTRIES | 5.7% |
1.5% |
-6.6% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses